Neuro-Endocrine and Neuropsychological Outcome After Aneurysmal Subarachnoid Hemorrhage (asah): A Prospective Cohort Study

Abstract

Objective: Neuropsychological sequelae are common after aneurysmal subarachnoid hemorrhage (aSAH) and may be associated with or caused by supposed hypothalamic-pituitary dysfunction. We evaluated the incidence of neuro-endocrine and neuropsychological deficits after aSAH and their interrelations in a standardized manner.

Methods: 26 patients (20 females) were prospectively screened for neuro-endocrine and neuropsychological deficits 3 and 6 months after aSAH. We measured GH, IGF-1, prolactin, LH, FSH, estradiol, TSH, fT4, total T3, testosterone, ACTH as well as cortisol before and after ACTH-stimulation. Neuropsychological analysis covered verbal comprehension, short term and working memory, visuospatial construction, figural memory, psychomotor speed, attention, and concentration.

Results: After 3 months central hypogonadism was observed in 2 patients accompanied by central hypothyroidism in 1 male subject. Central hypogonadism resolved spontaneously after 6 months in both. After 3 months, neuropsychological deficits were detected in 57% of the examined patients (44% attention deficits, 38% memory impairment, 12% psychomotor deficits). Neuropsychological deficits were still present in 53% after 6 months.

Conclusion: We found a low prevalence of neuro-endocrine and a high prevalence of neuropsychological deficits in patients 3 and 6 months after aSAH. Thus, the absent co-incidence of central hormonal and psychological dysfunction leaves a causal association questionable.

Key words

hypopituitarism - aneurysmal subarachnoid hemorrhage - neuropsychological deficit

References

• 1 Bederson JB, Connolly Jr ES, Batjer HH. et al . American Heart Association 2009 Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.  Stroke. 2009;  40 994-1025
• 2 Suarez JI, Tarr RW, Selman WR. Aneurysmal Subarachnoid Hemorrhage.  N Engl J Med. 2006;  354 387-396
• 3 Ogden JA, Mee EW, Henning M. A prospective study of impairment of cognition and memory and recovery after subarachnoid hemorrhage.  Neurosurgery. 1993;  33 572-586
• 4 Berry E, Jones RA, West CG. et al . Outcome of subarachnoid haemorrhage. An analysis of surgical variables, cognitive and emotional sequelae related to SPECT scanning.  Br J Neurosurg. 1997;  11 378-387
• 5 Bellebaum C, Schäfers L, Schoch B. et al . Clipping versus coiling: neuropsychological follow-up after aneurysmal subarachnoid haemorrhage (SAH).  J Clin Exp Neuropsychol. 2004;  26 1081-1092
• 6 Anderson SW, Todd MM, Hindman BJ. et al . IHAST Investigators. Effects of intraoperative hypothermia on neuropsychological outcomes after intracranial aneurysm surgery.  Ann Neurol. 2006;  60 518-527
• 7 Schneider HJ, Kreitschmann-Andermahr I, Ghigo E. et al . Hypothalamopituitary Dysfunction Following Traumatic Brain Injury and Aneurysmal Subarachnoid Hemorrhage. A Systematic Review.  JAMA. 2007;  298 1429-1438
• 8 Brabant G, Krogh Rasmussen A, Biller BM. et al . Clinical implications of residual growth hormone (GH) response to provocative testing in adults with severe GH deficiency.  J Clin Endocrinol Metab. 2007;  92 2604-2609
• 9 Lindholm J, Kehlet H. Re-evaluation of the clinical value of the 30 min ACTH test in assessing the hypothalamic-pituitary adrenocortical function.  Clin Endocrinol. 1987;  26 53-59
• 10 GH Research Society . Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society.  J Clin Endocrinol Metab. 2000;  85 3990-3993
• 11 Sievers C, Brübach K, Saller B. et al . On behalf of the German Pegvisomant Investigators. Change of symptoms and perceived health in acromegalic patients on pegvisomant therapy: a retrospective cohort study within the German Pegvisomant Observational Study (GPOS).  Clin Endocrinol (Oxf). 2009;  [Epub ahead of print]
• 12 Van den Berghe G. Novel insights into the neuroendocrinology of critical illness.  Eur J Endocrinol. 2000;  143 1-13
• 13 van den Berghe G, Weekers F, Baxter RC. et al . Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.  J Clin Endocrinol Metab. 2001;  86 3217-3226
• 14 Dimopoulou I, Kouyialis AT, Tzanella M. et al . High incidence of neuroendocrine dysfunction in long-term survivors of aneurysmal subarachnoid hemorrhage.  Stroke. 2004;  35 2884-2889
• 15 Aimaretti G, Ambrosio MR, Di Somma C. et al . Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study.  J Clin Endocrinol Metab. 2005;  90 6085-6092
• 16 Aimaretti G, Ambrosio MR, Di Somma C. et al . Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury.  Clin Endocrinol. 2004;  61 320-326
• 17 Kreitschmann-Andermahr I, Hoff C, Saller B. et al . Prevalence of Pituitary Deficiency in Patients after Aneurysmal Subarachnoid Hemorrhage.  J Clin Endocrinol Metab. 2004;  89 4986-4992
• 18 Kokshoorn N, Wassenaar M, Biermasz N. et al . Hypopituitarism following traumatic brain injury: the prevalence is affected by the use of different dynamic tests and different normal values.  Eur J Endocrinol. 2009;  [Epub ahead of print]

Correspondence